Physician profile
Kevin S Smith
NPI 1457388225
$6,832.12
in general payments reported to CMS, 2019-2025
13 companies · $397 in 2025
The $397 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,464 · 2020: $470 · 2021: $921 · 2022: $599 · 2023: $1,120 · 2024: $1,861 · 2025: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,628 · Education: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,628.34 |
| Education | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,061.19 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Activos 10 Bone Cement |
| Intuitive Surgical, INC. | $766.00 | 2024 | |
| Boston Scientific Corporation | $701.08 | 2019-2025 | Wavewriter Alpha Prime 16, Infinion 16 |
| Abbott Laboratories | $564.99 | 2019-2025 | Prodigy, Proclaim, Eterna |
| Medtronic USA, INC. | $469.70 | 2019-2020 | |
| Nevro Corp. | $363.53 | 2019-2023 | Senza |
| Flowonix Medical Incorporated | $267.81 | 2019 | |
| Nalu Medical, INC. | $184.28 | 2021-2024 | Nalu Neurostimulation System |
| Centinel Spine, LLC | $155.39 | 2019 | |
| Spr Therapeutics, INC | $147.78 | 2019-2025 | Sprint Pns System |
| Scilex Pharmaceuticals INC. | $103.34 | 2019-2022 | |
| Si-Bone, INC. | $26.55 | 2024 | |
| Shionogi INC | $20.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.